Ryk, a receptor regulating wnt5a-mediated neurogenesis and axon morphogenesis of ventral midbrain dopaminergic neurons

Stem Cells and Development

Volumn 22, Issue 15, 2013, Pages 2132-2144

  Blakely, Brette D ^a   Bye, Christopher R ^a   Fernando, Chathurini V ^a   Prasad, Asheeta A ^b   Jeroen Pasterkamp, R ^b,c   MacHeda, Maria L ^a   Stacker, Steven A ^a   Parish, Clare L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DISHEVELLED 2; DOPAMINE; PROTEIN TYROSINE KINASE; RYK KINASE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; KNOCKOUT MOUSE; MESENCEPHALON; MOUSE; NERVE CELL PLASTICITY; NERVE FIBER; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL; VARICOSIS;

ANIMALS; AXONS; DOPAMINERGIC NEURONS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEK293 CELLS; HUMANS; MESENCEPHALON; MICE; MICE, KNOCKOUT; MORPHOGENESIS; NEURAL STEM CELLS; NEUROGENESIS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; TISSUE CULTURE TECHNIQUES; WNT PROTEINS;

EID: 84880638198     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0066     Document Type: Article

References (53)

1. Macheda ML and SA Stacker. (2008). Importance of Wnt signaling in the tumor stroma microenvironment. Curr Cancer Drug Targets 8:454-465.
2. Fischer T, J Guimera, W Wurst and N Prakash. (2007). Distinct but redundant expression of the Frizzled Wnt receptor genes at signaling centers of the developing mouse brain. Neuroscience 147:693-711.
3. Gordon MD and R Nusse. (2006). Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429-22433.
4. Mao B, W Wu, Y Li, D Hoppe, P Stannek, A Glinka and C Niehrs. (2001). LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411:321-325.
5. Witte F, O Bernatik, K Kirchner, J Masek, A Mahl, P Krejci, S Mundlos, A Schambony, V Bryja and S Stricker. (2010). Negative regulation of Wnt signaling mediated by CK1-phosphorylated Dishevelled via Ror2. FASEB J 24:2417-2426.
6. Wehrli M, ST Dougan, K Caldwell, L O'Keefe, S Schwartz, D Vaizel-Ohayon, E Schejter, A Tomlinson and S DiNardo. (2000). arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407:527-530.
7. Halford MM, J Armes, M Buchert, V Meskenaite, D Grail, ML Hibbs, AF Wilks, PG Farlie, DF Newgreen, CM Hovens and SA Stacker. (2000). Ryk-deficient mice exhibit craniofacial defects associated with perturbed Eph receptor crosstalk. Nat Genet 25:414-418.
8. Castelo-Branco G, J Wagner, FJ Rodriguez, J Kele, K Sousa, N Rawal, HA Pasolli, E Fuchs, J Kitajewski and E Arenas. (2003). Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc Natl Acad Sci USA 100:12747-12752.
9. Prakash N, C Brodski, T Naserke, E Puelles, R Gogoi, A Hall, M Panhuysen, D Echevarria, L Sussel, et al. (2006). A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development 133:89-98.
10. Parish CL, G Castelo-Branco, N Rawal, J Tonnesen, AT Sorensen, C Salto, M Kokaia, O Lindvall and E Arenas. (2008). Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J Clin Invest 118:149-160.
11. Andersson ER, N Prakash, L Cajanek, E Minina, V Bryja, L Bryjova, TP Yamaguchi, AC Hall, W Wurst and E Arenas. (2008). Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo. PLoS One 3:e3517.
12. Castelo-Branco G, KM Sousa, V Bryja, L Pinto, J Wagner and E Arenas. (2006). Ventral midbrain glia express region-specific transcription factors and regulate dopaminergic neurogenesis through Wnt-5a secretion. Mol Cell Neurosci 31:251-262.
13. Rawal N, G Castelo-Branco, KM Sousa, J Kele, K Kobayashi, H Okano and E Arenas. (2006). Dynamic temporal and cell type-specific expression of Wnt signaling components in the developing midbrain. Exp Cell Res 312: 1626-1636.
14. Blakely BD, CR Bye, CV Fernando, MK Horne, ML Macheda, SA Stacker, E Arenas and CL Parish. (2011). Wnt5a regulates midbrain dopaminergic axon growth and guidance. PLoS One 6:e18373.
15. Stuebner S, T Faus-Kessler, T Fischer, W Wurst and N Prakash. (2010). Fzd3 and Fzd6 deficiency results in a severe midbrain morphogenesis defect. Dev Dyn 239:246-260.
16. Wang Y, N Thekdi, PM Smallwood, JP Macke and J Nathans. (2002). Frizzled-3 is required for the development of major fiber tracts in the rostral CNS. J Neurosci 22:8563-8573.
17. Fenstermaker AG, AA Prasad, A Bechara, Y Adolfs, F Tissir, A Goffinet, Y Zou and RJ Pasterkamp. (2010). Wnt/planar cell polarity signaling controls the anterior-posterior organization of monoaminergic axons in the brainstem. J Neurosci 30:16053-16064.
18. Zhou CJ, KI Pinson and SJ Pleasure. (2004). Severe defects in dorsal thalamic development in low-density lipoprotein receptor-related protein-6 mutants. J Neurosci 24:7632-7639.
19. Castelo-Branco G, ER Andersson, E Minina, KM Sousa, D Ribeiro, C Kokubu, K Imai, N Prakash, W Wurst and E Arenas. (2010). Delayed dopaminergic neuron differentiation in Lrp6 mutant mice. Dev Dyn 239:211-221.
20. Callahan CA, MG Muralidhar, SE Lundgren, AL Scully and JB Thomas. (1995). Control of neuronal pathway selection by a Drosophila receptor protein-tyrosine kinase family member. Nature 376:171-174.
21. Yoshikawa S, RD McKinnon, M Kokel and JB Thomas. (2003). Wnt-mediated axon guidance via the Drosophila Derailed receptor. Nature 422:583-588.
22. Lu W, V Yamamoto, B Ortega and D Baltimore. (2004). Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell 119:97-108.
23. Schmitt AM, J Shi, AM Wolf, CC Lu, LA King and Y Zou. (2006). Wnt-Ryk signalling mediates medial-lateral retinotectal topographic mapping. Nature 439:31-37.
24. Keeble TR, MM Halford, C Seaman, N Kee, M Macheda, RB Anderson, SA Stacker and HM Cooper. (2006). The Wnt receptor Ryk is required for Wnt5a-mediated axon guidance on the contralateral side of the corpus callosum. J Neurosci 26:5840-5848.
25. Liu Y, J Shi, CC Lu, ZB Wang, AI Lyuksyutova, XJ Song and Y Zou. (2005). Ryk-mediated Wnt repulsion regulates posterior-directed growth of corticospinal tract. Nat Neurosci 8:1151-1159.
26. Fradkin LG, M van Schie, RR Wouda, A de Jong, JT Kamphorst, M Radjkoemar-Bansraj and JN Noordermeer. (2004). The Drosophila Wnt5 protein mediates selective axon fasciculation in the embryonic central nervous system. Dev Biol 272:362-375.
27. Zhong J, HT Kim, J Lyu, K Yoshikawa, M Nakafuku and W Lu. (2011). The Wnt receptor Ryk controls specification of GABAergic neurons versus oligodendrocytes during telencephalon development. Development 138:409-419.
28. Lyu J, V Yamamoto and W Lu. (2008). Cleavage of the Wnt receptor Ryk regulates neuronal differentiation during cortical neurogenesis. Dev Cell 15:773-780.
29. Sawamoto K, N Nakao, K Kobayashi, N Matsushita, H Takahashi, K Kakishita, A Yamamoto, T Yoshizaki, T Terashima, et al. (2001). Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons. Proc Natl Acad Sci USA 98:6423-6428.
30. Kele J, N Simplicio, AL Ferri, H Mira, F Guillemot, E Arenas and SL Ang. (2006). Neurogenin 2 is required for the development of ventral midbrain dopaminergic neurons. Development 133:495-505.
31. Bye CR, LH Thompson and CL Parish. (2012). Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into Parkinsonian mice. Exp Neurol 236:58-68.
32. Pfaffl MW. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
33. Turner BJ, NJ Parkinson, KE Davies and K Talbot. (2009). Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model. Neurobiol Dis 34:511-517.
34. Kolk SM, RA Gunput, TS Tran, DM van den Heuvel, AA Prasad, AJ Hellemons, Y Adolfs, DD Ginty, AL Kolodkin, et al. (2009). Semaphorin 3F is a bifunctional guidance cue for dopaminergic axons and controls their fasciculation, channeling, rostral growth, and intracortical targeting. J Neurosci 29:12542-12557.
35. Gundersen HJ, P Bagger, TF Bendtsen, SM Evans, L Korbo, N Marcussen, A Moller, K Nielsen, JR Nyengaard, et al. (1988). The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96:857-881.
36. West MJ, L Slomianka and HJ Gundersen. (1991). Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anatomical Record 231:482-497.
37. Parish CL, DI Finkelstein, J Drago, E Borrelli and MK Horne. (2001). The role of dopamine receptors in regulating the size of axonal arbors. J Neurosci 21:5147-5157.
38. West MJ and HJ Gundersen. (1990). Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comparative Neurol 296:1-22.
39. Braendgaard H, SM Evans, CV Howard and HJ Gundersen. (1990). The total number of neurons in the human neocortex unbiasedly estimated using optical disectors. J Microscopy 157:285-304.
40. Sousa KM, JC Villaescusa, L Cajanek, JK Ondr, G Castelo-Branco, W Hofstra, V Bryja, C Palmberg, T Bergman, et al. Wnt2 regulates progenitor proliferation in the developing ventral midbrain. J Biol Chem 285:7246-7253.
41. Bovolenta P, J Rodriguez and P Esteve. (2006). Frizzled/RYK mediated signalling in axon guidance. Development 133:4399-4408.
42. Keeble TR and HM Cooper. (2006). Ryk: a novel Wnt receptor regulating axon pathfinding. Int J Biochem Cell Biol 38:2011-2017.
43. Hollis ER, and Y Zou. (2012). Expression of the Wnt signaling system in central nervous system axon guidance and regeneration. Front Mol Neurosci 5:5.
44. Li L, BI Hutchins and K Kalil. (2009). Wnt5a induces simultaneous cortical axon outgrowth and repulsive axon guidance through distinct signaling mechanisms. J Neurosci 29:5873-5883.
45. Hutchins BI, L Li and K Kalil. (2011). Wnt/calcium signaling mediates axon growth and guidance in the developing corpus callosum. Dev Neurobiol 71:269-283.
46. Vanden Heuvel DM and RJ Pasterkamp. (2008). Getting connected in the dopamine system. Prog Neurobiol 85:75-93.
47. Schambony A and D Wedlich. (2007). Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway. Dev Cell 12:779-792.
48. Gonzalez-Sancho JM, KR Brennan, LA Castelo-Soccio and AM Brown. (2004). Wnt proteins induce dishevelled phosphorylation via an LRP5/6-independent mechanism, irrespective of their ability to stabilize beta-catenin. Mol Cell Biol 24:4757-4768.
49. Wouda RR, MR Bansraj, AW de Jong, JN Noordermeer and LG Fradkin. (2008). Src family kinases are required for WNT5 signaling through the Derailed/RYK receptor in the Drosophila embryonic central nervous system. Development 135:2277-2287.
50. Fradkin LG, JM Dura and JN Noordermeer. (2010). Ryks: new partners for Wnts in the developing and regenerating nervous system. Trends Neurosci 33:84-92.
51. Kohn AD and RT Moon. (2005). Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium 38: 439-446.
52. Andre P, Q Wang, N Wang, B Gao, A Schilit, MM Halford, SA Stacker, X Zhang and Y Yang. (2012). The wnt coreceptor ryk regulates wnt/planar cell polarity by modulating the degradation of the core planar cell polarity component vangl2. J Biol Chem 287:44518-44525.
53. Macheda ML, WW Sun, K Kugathasan, BM Hogan, NI Bower, MM Halford, YF Zhang, BE Jacques, GJ Lieschke, A Dabdoub and SA Stacker. (2012). The Wnt receptor Ryk plays a role in mammalian planar cell polarity signaling. J Biol Chem 287:29312-29323.